Stiefel licenses Sebiprox to Ferrer

Stiefel Laboratories, the world's largest independent dermatologycompany, says that its European affiliate, Stiefel Laboratories (Ireland) Ltd, has signed an agreement to license its Sebiprox (active ingredient ciclopirox) dandruff shampoo to Grupo Ferrer International SA of Spain.

Sold by Stiefel under various brand names in Spain, France, Germany, Italy and Morocco as a treatment for dandruff and other forms of seborrheic dermatitis of the scalp, Sebiprox is the only antifungal dandruff shampoo that is reimbursable under most major insurance plans in Spain.

The product will be manufactured and supplied to Ferrer by Stiefel from its facility in Ireland. Ferrer will re-brand and sell the shampoo as part of its popular Ciclochem line of antifungal skin and hair-care products. Stiefel will continue to market the product to its core dermatologist customers under the Sebiprox name in Spain and throughout its other territories.